Drugs / Cryosupernatant plasma
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00411801 Comparator | May 2007 → Feb 2008 | thrombotic thrombocytopenic purpura | Octapharma | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cryosupernatant plasma | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00411801 ↗ |
| Route | Intravenous | “Participants will receive cryosupernatant plasma intravenously” NCT00411801 ↗ |